We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 18.70
High: 18.70
Low: 18.70
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

30 Sep 2019 14:21

RNS Number : 1862O
Directa Plus PLC
30 September 2019
 

30 September 2019

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

Directa Plus plc

("Directa Plus" or the "Company")

Half Year Report

 

Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce its half year results for the six months ended 30 June 2019.

 

Directa Plus's focus is on the sectors where it has established strong commercial advantage through developing and launching products with a technological lead: Environmental, based on our Grafysorber® product for treating oil contaminated water; Textiles (based on our G+ products and technology); Composites (including our asphalt additive in Ecopave; and, Elastomers (including retread tyres)

 

Summary

 

Financial and Corporate

·; Revenue for the six months to 30 June 2019 increased by 56 per cent to €894,693 (2018: €573,822)

·; Loss before tax was similar to last year at €1,778,890 (2018: loss of €1,753,053)

·; Loss per share was €0.03 (2018: €0.04)

·; Cash at period end was €4,760,951 (€4,947,457 at the end of the comparable period and €5,503,884 as at 31 December 2018)

 

Target market progress

Environmental

·; Strategic decision on developing a full decontamination service - not just a product - for the Company's Grafysorber® oil adsorber product to international oil and gas markets

·; Post-period end announced the award of a supply and service contract to treat and recover crude oil from producing wells onshore Europe using Grafysorber® for a value of approximately €150,000 over the next six months

 

Textiles

·; Luxury: Signed an exclusive agreement with Loro Piana in March for the commercialisation of Loro Piana fabrics and garments enriched by the Company's G+ technology. With an initial duration of three years the contract has a minimum value of €800,000 mainly weighted in 2020 and 2021

·; Workwear: Signed an exclusive agreement with Alfredo Grassi S.p.A. in May, to broaden existing collaboration in the development of graphene enhanced workwear and expand into the military outerwear market in Italy, part of Europe and North Africa

·; Denim: Continuing to evaluate potential new collaborations to gain increased market presence for our innovative denim technology based on Planar Thermal Circuit

 

 

Composites and Elastomers

·; Announced in April the successful results of a first commercial test of an asphalt concrete, Ecopave, in partnership with Iterchimica - confirming that using G+ products as an additive will extend the life and resilience of asphalts on roads

·; Further testing will see Ecopave laid on new trial sections of highway in the second half of 2019 in Italy (roads and airports), and UK with USA and Oman trial to follow in 2020.

 

Intellectual Property

·; Significant new patents filed or granted including:

o a US patent covering our manufacturing process for graphene nanoplatelets

o a US patent covering our technology to produce a water-based dispersion of pristine graphene nanoplatelets which allows Directa Plus to create an ink based on its G+ graphene product

o an Italian patent for the process of removing hydrocarbons from water exploiting Grafysorber®

o an additional Italian patent covering the use of our G+ graphene in the manufacture of golf balls

o a Chinese patent, covering Directa Plus' unique process for manufacturing graphene nanoplatelets

 

·; IP portfolio now contains a suite of patents, across global jurisdictions, of 27 granted, and a further 20 pending approval

 

Giulio Cesareo, Founder & CEO, said:

"2019 started well for the Company as we continued to deliver our strategy of using pristine graphene nanoplatelets to enhance customers' products and to move up the value chain. As we partner initially with Italian based multinationals to create reference products, we can leverage those products and experience to enter wider global markets. This proven strategy has allowed us to gain increasing international commercial traction in our four key vertical markets: environmental, textiles, composites and elastomers.

 

"Our international footprint is expanding, with our total revenues up by 56 per cent during the period and the visibility of our products in the world's largest market for graphene, the United States, increased materially as a result of our initiatives.

 

"Within Textiles, we have been working with Grassi on a material graphene enhanced workwear order, albeit we have seen some slippage in the final ordering process from the end customer such that we now expect that it is more likely that only a small part of this order will be reflected in this years' revenues.

 

"In the Environmental vertical we are going to invest to fully integrate Directa's environmental activities, creating a full service graphene based solution for the oil and gas industry, via the acquisition of Setcar which is also being announced today.

 

"As we look forward to the reminder of 2019 and beyond, we expect to make further progress in all of our key vertical markets and continue to grow our business."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies, Will Goode (Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle, Mia Gardner

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Edward Lee, Barnaby Hayward

 

 

 

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

Review of Operations

 

In the first half of 2019, Directa Plus continued to make good progress on its strategy to use its pristine graphene nanoplatelets to enhance customers' products and to move up the value chain. By partnering initially with Italian based multinationals to create reference products, we can leverage those products and experience to enter wider global markets. This proven strategy has allowed us to gain increasing international commercial traction in our four key vertical markets: environmental, textiles, composites and elastomers.

 

Environmental

In the environmental segment, the first half saw us working to finalise our plans to offer a full decontamination service for the Company's Grafysorber® pollutant adsorber product to international oil and gas and marine markets. Offering a full service enables Directa Plus to capture significant additional value for shareholders.

 

In line with this commercialisation strategy, we announced shortly after the period end, in July, the award of a supply and service contract to treat and recover crude oil from producing wells onshore Europe. The contract commenced on 1 August 2019. We will treat several thousand cubic meters of sludges and by-products for a value of approximately €150,000 over the next six months, using the Company's Grafysorber® technology. Directa Plus is providing a full service to the customer, an international oil and gas company, with the supply of a mobile treatment unit and we are operating the recovery process.

 

The application of the Grafysorber® technology has the potential to both improve the production process and reduce costs through recovering crude oil from sludges and water associated with extraction and by avoiding expensive disposal as an untreated waste. In addition, our treatment will allow the ritualization of already injected produced water (water that comes out of the oil or gas reservoir as part of the production process), reducing usage of water resources. Grafysorber® is sustainably produced, non-flammable and reusable, with the adsorbed hydrocarbons recoverable.

 

Textiles

In textiles, our business has continued to grow with new applications, new materials and new territories. In March, we announced that Directa Plus had signed an exclusive agreement with Loro Piana for the commercialisation of Loro Piana fabrics and garments enriched by the Company's G+ technology. This was our first material engagement with the luxury sector and lead to the launch of the first such textile at the 29th Milano Unica exhibition at the beginning of July. The agreement with Loro Piana is on a worldwide basis with an initial duration of three years for a minimum value of €800,000.

 

We were delighted to conclude this agreement. The extreme sensitivity of Loro Piana to the environment along its entire value chain fits perfectly with our own culture: all of our products are hypoallergenic, non-toxic and sustainably produced. Thanks to the agreement, Directa Plus's G+ technology will be entering Loro Piana's prestigious supply chain and will benefit from its global brand awareness and its reputation for the highest quality standards.

 

In the workwear sector, we also continued to make progress. In May, we announced that we had signed an exclusive agreement with Alfredo Grassi S.p.A., to broaden an existing collaboration in the development of graphene enhanced workwear and to expand into the military outerwear market. We have been working with Grassi for the last three years and our partnership has already produced more than 80,000 metres of fabric enhanced with G+ pristine graphene nanoplatelets, that have been used in the manufacture of thousands of garments.

 

The agreement between Directa Plus and Grassi provides for up to three years of exclusive co-operation in some countries in Europe and in North Africa in the workwear and military markets. The main objectives are to increase the uptake of graphene enhanced, advanced workwear and military outerwear to develop and market new products; and, to offer end users the maximum level of sustainability along the entire supply chain. As with many of our customers, we share a culture with Grassi of focusing care and attention on innovation and sustainability with the safety and wellness of the end users paramount.

 

Finally, following the launch of a G+ enhanced denim last year with Arvind, we are continuing to evaluate potential new collaborations in the denim arena to gain increased market presence for our innovative denim technology.

 

Composites and Elastomers

In Composites, we announced in April with our partner Iterchimica, the first official results from the trial re-surfacing of a section of an Italian road with the G+ upgraded asphalt super modifier containing Directa Plus G+ graphene. The trial was the first commercial test of an asphalt concrete, Ecopave, with this innovative graphene-enhanced super modifier and involved the refurbishment of the two upper layers of a 1 km-long section of an road. It was carried out by Iterchimica with support from an independent laboratory. The performance of the road surface has been constantly monitored since November 2018.

 

The trial, comparing asphalt concrete with the super modifier to a traditional asphalt surfacing, was successful in all respects. Service life was increased by over 250 per cent; resistance to the passage of vehicles showed an increase of 35 per cent; resistance to deformation at the same load showed an improvement of 46 per cent at 40°C; and, rutting values (tracks left by tyres) were 35 per cent lower at 60°C.

 

The graphene-enhanced super modifier used in the trial was the result of a three-year research project with a patent filed in 2017. New technologies such as this and the rejuvenation of old paving will help to meet Italy's Green and Circular Economy standards. Once laid, asphalt concrete with the super modifier can be completely recycled, reducing the extraction of new materials from quarries and first-use bitumen. Ecopave will be laid on new trial sections of highway in the second half of 2019 in Italy, UK, and in USA and Oman in 2020.

 

In Elastomers, we are proceeding with the retread tyres application with positive results coming from the tests and trials. Leveraging on the G+ unique performances we entered into discussion with a player in the electric mobility US market to assess the opportunity to implement the use of tires enhanced with G+ graphene to reduce rolling resistance.

 

Intellectual Property

As part of our strategy to increase our presence in international markets, we have paid particular attention to our intellectual property. This has resulted in the grant of a number of additional patents both in Europe and internationally. The first of these was the grant of the Italian patent for the process of removing hydrocarbons from water exploiting Grafysorber® and we are now in the process of completing the necessary steps to file the patent in other countries.

 

Next up was an additional Italian patent covering the use of our G+ graphene in the manufacture of golf balls, which can provide a series of beneficial features that offer opportunities to develop a new generation of golf ball for both professional and amateur players.

 

This was followed by the grant of a Chinese patent, covering Directa Plus' unique process for manufacturing graphene nanoplatelets. Our unique exfoliation technology is chemical free, has an extremely high yield, and can be varied to produce graphene nanoplatelets with specific morphologies. This means that G+ products are safe for human health, can be tailor-made to meet customers' needs, and the high-yields create competitive prices. Gaining legal recognition of the Company's proprietary, chemical-free graphene production process in China will allow us to enter into larger Chinese supply chains more easily in the future.

 

Lastly, our focus on developing greater traction in the US has lead us to file for more patents in that territory. In the first half of the year, we secured two US patents. The first covered our manufacturing process for graphene nanoplatelets and the second covered our technology to produce a water-based dispersion of pristine graphene nanoplatelets which allows Directa Plus to create an ink based on its G+ graphene product. The grant of these US patents is a key development in launching our products into the United States. The sustainable nature of our production process, using no chemicals, is proving to be an attractive point of difference in negotiations with large US companies.

 

Post period we have received notice of allowance for two European patents: the first covering our technology to produce a water-based dispersion of pristine graphene nanoplatelets while the second covers the application of our G+ product as a flame-retardant solution.

 

Our IP portfolio now contains a suite of patents, across global jurisdictions, of 27 granted, and a further 20 pending approval.

 

Financial

Revenue for the six months to 30 June 2019 increased by 56 per cent to €894,693 (1H2018: €573,822), driven by the Textile sector. The significant increase in raw material and consumables used at €612,532 (1H2018: €255,499) is directly correlated with the increase in revenues derived from the textile industry which require the purchasing of fabrics. Employee benefits expenses were tightly controlled at €980,007 (1H2018: €956,325) with full time equivalent increasing by one to 24.

 

Other expenses showed a slight increase of 5.7 per cent to €892,911 (1H2018: €844,335). Despite maintaining a cautious cost control, we continue to grow the amount of P&L expenses related to consultancy services and to travel and marketing. These are vital to expedite the development of the core applications and to boost revenues and to create and maintain business relationships. As result of the slight increase in costs, EBITDA loss for the period remained aligned with 1H2018 at €1.45m.

 

Loss before tax was similar to last year at €1,778,890 (2018: loss of €1,753,053) reflecting a positive effect from finance expenses income of €38,160 (1H2018: 4,352). Loss per share was €0.03 (2018: €0.04). 

 

 

EBITDA (€m)

1H 2019

1H 2018

Result from operating activities

(1.82)

(1.76)

Depreciation and amortisation

0.37

0.33

EBITDA

(1.45)

(1.43)

 

An investment in tangible and intangible assets of €0.13m was incurred during the period, mainly related to IP development (€0.03m) and capitalisation of development costs (€0.07m).

 

A capital raise was undertaken between December 2018 and January 2019, raising a total gross amount of £3.45 million (€3.84m) with the details provided in the last Annual Report. The effect of the Conditional Placing and the Open Offer (settled on 9 January 2019) and equal to £1.32m (€1.47m) are reflected in this period's cash position.

 

Cash at period end was €4.8m (€4.9m at the end of the comparable period and €5.5m as at 31 December 2018). The Directors are satisfied that the Group has adequate resources to continue in operational existence at least 12 months from approving these interim financial statements. Accordingly, these interim financial statements have been prepared on a going concern basis as the Directors are of the opinion that the Group has sufficient funds to meet their ongoing working capital and committed capital expenditure requirements. In making this assessment, the Directors considered the budgets, the cash flow forecasts and associated risks.

 

Outlook

2019 started well for us with our strategy continuing to deliver and we expect to make further progress in all of our key vertical markets during the remainder of the year.

 

Within Textiles, we have been working with Grassi on a material graphene enhanced workwear order, albeit we have seen some slippage in the final ordering process from the end customer such that we now expect that it is more likely that only a small part of this order will be reflected in this years' revenues.

 

In the Environmental business we are going to invest to create a full service graphene based solution for the oil and gas industry, via the acquisition of Setcar, which is also being announced today. Moreover, we are going to extend the range of the Grafysorber based industrial applications as well as improving Grafysorber's properties, targeting the adsorption of several pollutants. A significant benefit of the proposed acquisition of Setcar is the expected signing of several commercial contracts for the provision of environmental services to a number of multinational oil and gas companies. These contracts will extend across several years starting between October 2019 and late 2020 and represent a revenue opportunity of at least €8 million.

 

With regards to Textiles, leveraging on our commercial endorsements, we are going to boost market presence and quality of revenues as well as improving the Planar Thermal Circuit properties, targeting electrical conductivity and smart textiles. Moreover we would like to invest in developing a G+ graphene yarn.

 

To conclude, the key focus of our company-maker verticals is well defined and our international footprint is expanding with increasing visibility for Directa Plus and our products in the world's largest market for graphene, the United States.

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 30 June 2019

In euro

Note

(Unaudited)

(Unaudited)

Audited

 

30 Jun 2019

30 Jun 2018

31 Dec 2018

Continuing operations

Revenue

894,693

573,822

2,253,293

Other income

52,879

83,615

248,695

Changes in inventories of finished goods and work in progress

90,350

(31,491)

(133,382)

Raw materials and consumables used

(612,532)

(255,499)

(1,299,078)

Employee benefits expenses

(980,007)

(956,325)

(2,112,650)

Depreciation and amortisation

(369,522)

(327,202)

(674,919)

Other expenses

2

(892,911)

(844,325)

(2,197,670)

Results from operating activities

(1,817,050)

(1,757,405)

(3,915,711)

 

Finance expenses income (expenses)

 

 

 

38,160

 

4,352

(40,703)

Net finance costs

38,160

4,352

(40,703)

Loss before tax

(1,778,890)

(1,753,053)

(3,956,414)

Tax expense

-

(1,237)

(414)

Loss after tax

(1,778,890)

(1,754,290)

(3,956,828)

Loss from continuing operations

(1,778,890)

(1,754,290)

(3,956,828)

Loss of the period

(1,778,890)

(1,754,290)

(3,956,828)

Other Comprehensive income items that will not be reclassified to profit or loss

Defined Benefit Plan remeasurement gains and losses

3,585

14,600

1,219

Other comprehensive income for the year (net of tax)

3,585

14,600

1,219

Total comprehensive income for the year

(1,775,305)

(1,739,690)

(3,955,609)

 

 

 

Loss attributable to

 

 

 

Owner of the Parent

(1,778,030)

(1,767,071)

(3,961,259)

Non-controlling interests

(860)

12,781

4,431

 

 

(1,778,890)

(1,754,290)

(3,956,828)

Total Comprehensive (expenses)/ income attributable to

 

 

 

Owner of the Parent

(1,774,445)

(1,752,471)

(3,960,040)

Non-controlling interests

(860)

12,781

4,431

 

 

(1,775,305)

(1,739,690)

(3,955,609)

Loss per share

Basic loss per share

 

(0.03)

(0.04)

(0.09)

Diluted loss per share

 

(0.03)

(0.04)

(0.09)

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 June 2019

 

In euro

Note

(Unaudited)

(Unaudited)

Audited

 

30 Jun 2019

30 Jun 2018

31 Dec 2018

Assets

 

 

 

Intangible assets

1,445,453

1,537,927

1,467,478

Property, plant and equipment

950,707

1,192,772

1,062,435

Right-of-use assets

418,750

-

-

Non-current assets

2,814,910

2,730,699

2,529,913

Inventories

952,634

964,176

862,284

Trade and other receivables

1,099,246

767,366

2,059,217

Cash and cash equivalent

4,760,951

4,947,457

5,503,884

Current assets

6,812,831

6,678,999

8,425,385

Total assets

9,627,741

9,409,698

10,955,298

 

 

Equity

Share capital

161,815

142,628

154,465

Share premium

23,426,027

19,973,996

22,104,240

Retained Earnings

(15,795,062)

(11,925,574)

(14,044,656)

Equity attributable to owners of Group

7,792,780

8,191,050

8,214,049

Non-controlling interest

26,501

35,711

27,361

Total equity

7,819,281

8,226,761

8,241,410

 

Liabilities

Loans and borrowings

28,395

158,459

57,011

Right of use liabilities

348,878

-

-

Employee benefits

364,372

287,488

335,132

Non-current liabilities

741,645

445,947

392,143

Loans and borrowing

110,142

182,569

226,823

Right of use liabilities

72,403

-

-

Trade payables and other payables

884,270

554,421

2,094,922

Current liabilities

1,066,815

736,990

2,321,745

Total liabilities

1,808,460

1,182,937

2,713,888

Total equity and liabilities

9,627,741

9,409,698

10,955,298

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the six months ended 30 June 2019

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Share

Share

Retained Earnings

Total

Non-controlling

Total

In euro

Capital

premium

interests

Equity

Balance at 31 December 2017

142,628

19,973,996

(10,250,224)

9,866,400

22,930

9,889,329

Total comprehensive (expense)/income for the year

Loss for the year period

(1,767,071)

(1,767,071)

12,781

(1,754,290)

Total other comprehensive (expense)/income

14,600

14,600

14,600

Total comprehensive (expense)/income for the period

(1,752,471)

(1,752,471)

12,781

(1,739,690)

Share-based payment

77,123

77,123

77,123

Balance at 30 June 2018

142,628

19,973,996

(11,925,574)

8,191,050

35,711

8,226,761

Total comprehensive (expense)/income for the year

Loss of the year

(3,961,259)

(3,961,259)

4,431

(3,956,828)

Total other comprehensive (expense)/income

1,219

1,219

1,219

Total comprehensive (expense)/income for the period

(3,960,040)

(3,960,040)

4,431

(3,955,609)

Capital raised

11,837

2,355,548

2,367,385

2,367,385

Expenditure related to the issuance of shares

(225,304)

(225,304)

(225,304)

Share-based payment

165,610

165,610

165,610

Balance at 31 December 2018

154,465

22,104,240

(14,044,656)

8,214,049

27,361

8,241,410

Total comprehensive (expense)/income for the year

Loss of the Period

(1,778,030)

(1,778,030)

(860)

(1,778,890)

Total other comprehensive (expense)/income

3,585

3,585

3,585

Total comprehensive (expense)/income for the period

(1,774,445)

(1,774,445)

(860)

(1,775,305)

Capital raised

7,350

1,462,727

1,470,077

1,470,077

Expenditure related to the issuance of shares

(140,940)

(140,940)

(140,940)

Share-based payment

24,039

24,039

24,039

Balance at 30 June 2019

161,815

23,426,027

(15,795,062)

7,792,780

26,501

7,819,281

CONSOLIDATED STATEMENT OF CASH FLOW

For the six months ended 30 June 2019

(Unaudited)

(Unaudited)

Audited

30 Jun 2019

30 Jun 2018

31 Dec 2018

 

Loss for the year before tax

(1,778,890)

(1,753,053)

(3,956,414)

Adjusted for:

Depreciation

211,322

175,672

357,014

Amortisation of intangible assets

158,200

151,530

317,905

Share based option payment cost

24,039

77,124

165,610

Finance income

(1,968)

(15,119)

(4,440)

Finance expense

(36,193)

10,767

45,143

 

Operating cash flow before working capital changes

(1,423,490)

(1,353,079)

(3,075,182)

Decrease / (Increase) in inventories

(90,350)

31,490

133,382

Decrease / (Increase) in trade and other receivables, prepayments

959,971

394,345

(897,506)

(Decrease) / Increase in trade and other payables

(1,276,236)

(762,431)

758,397

Increase / (decrease) in provisions and employee benefits

28,874

16,853

47,175

Net cash used in operating activities

(1,801,231)

(1,672,822)

(3,033,734)

Cash flows from investing activities

Interest received

1,968

1,756

4,440

Investment in intangible assets

(107,498)

(140,127)

(207,158)

Acquisition of property, plant and equipment

(24,620)

(61,053)

(120,456)

Net cash used in investing activities

(130,150)

(199,424)

(323,174)

 

 

 

 

Cash flows from financing activities

Proceeds from Capital raise

1,470,077

-

2,367,385

Expenditure related to the issuance of shares

(140,940)

-

(225,304)

Interest Paid

(11,736)

(7,563)

(16,329)

New Borrowings

-

-

66,607

Repayment of borrowings

(180,833)

(115,543)

(239,344)

Net cash generated from financing activities

1,136,568

(123,106)

1,953,015

Net increase in cash and cash equivalent

(794,813)

(1,995,352)

(1,403,893)

Effect of exchange rate changes

51,880

13,364

(21,669)

Cash and cash equivalents at beginning of the period

5,503,884

6,929,446

6,929,446

Cash and cash equivalents at end of the period

4,760,951

4,947,457

5,503,884

 

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the 6 months ended 30 June 2018

 

1. Basis of preparation

(a) Statement of compliance

The financial information contained in this announcement does not constitute statutory financial statements within the meaning of Section 435 of the Companies Act 2006.

 

The financial information for the six months ended 30 June 2019 is unaudited. In the opinion of the directors, the financial information for the period fairly represents the financial position of the Group. Results of operations and cash flows for the period are in compliance with International Financial Reporting Standards as adopted by the EU ('EUIFRS'). The accounting policies, estimates and judgements applied are consistent with those disclosed in the Group's statutory financial statements for the year ended 31 December 2018. The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the full annual report for the year ended 31 December 2018.

 

All financial information is presented in Euro, unless otherwise disclosed.

 

The Directors of the Company approved the financial information included in these Interim condensed consolidated financial statements on 30 September 2019.

 

(b) Basis of measurement

The financial statements have been prepared on the historical cost basis unless otherwise stated.

 

(c) New standards adopted for the period

Effective from 1 January 2019, the Group adopted IFRS 16 - Leases (IFRS 16).

 

The Group elected to apply the modified retrospective approach which does not require restatement of comparative periods. As a result, lease liabilities were recognized in the opening consolidated balance sheet as at 1 January 2019 at an amount equal to the Group's remaining lease payments discounted using the Group's incremental borrowing rate. Additionally, the Group elected to measure right-of-use assets by reference to the measurement of the lease liabilities on the same date. As a result, net assets were not impacted. There was also no impact on the Group's equity at 1 January 2019.

 

On 1 January 2019, the Group recognised right-of-use assets and lease liabilities of Eur 456,819.

 

Under IFRS 16 the Group amortises its right-to-use assets and accretes interests on its lease liabilities. As at 30 June 2019, the carrying value of the right-of-use assets amounted to Eur 418,750 and the carrying value of the lease liabilities amounted to Eur 421,281.

 

(d) Functional and presentation currency

These financial statements are presented in Euro ('€') and is considered by the Directors to be the most appropriate presentation currency to assist the users of the financial statements. The functional currency of the Company and operating subsidiary is Euro ('€').

 

(e) Going concern

As a result of this review, the Directors believe that the Company has sufficient resources and working capital to meet their present and foreseeable obligations for a period of at least twelve months from approval of these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the Company financial statements.

 

2. Results from operating activities

Other expenses include:

 €

30 Jun 2019

30 Jun 2018

31 Dec 2018

 Technical Consultancies

239,165

206,006

478,879

 General Consultancies

362,539

277,317

628,628

 G&A

93,612

131,123

214,365

 Travel and marketing

106,731

89,273

366,153

 Rent and Lease

33,337

68,274

140,816

 Other expenses

57,527

72,332

368,829

Total

892,911

844,325

2,197,670

 

3. Earnings Per Share

The earnings per share have been calculated using the weighted average of ordinary shares. The Company was loss making for all periods presented. Therefore the dilutive effect of share options has not been taken account of in the calculation of diluted earnings per share, since this would decrease the loss per share for each of the period reported.

 

 

Change in

Total

Weighted

number of

number of

number of

ordinary

ordinary

ordinary

shares

shares

Days

shares

At 30 June 2017

-

44,212,827

182

44,212,827

At 31 December 2017

-

44,212,827

366

44,212,827

At 30 June 2018

-

44,212,827

182

44,212,827

At 31 December 2018

4,256,000

48,468,827

365

44,376,071

At 30 June 2019

2,647,609

51,116,436

182

50,970,963

 

Earnings per share

 

 

 

 

30 Jun 2019

30 Jun 2018

31 Dec 2018

Loss for the year

(1,778,890)

(1,767,071)

(3,956,828)

Weighted average number of shares:

 

 

 

- Basic

50,970,963

44,212,827

44,376,071

- Diluted

50,970,963

44,212,827

44,376,071

Loss per share

 

 

 

- Basic

(0.03)

(0.04)

(0.09)

- Diluted

(0.03)

(0.04)

(0.09)

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR CKKDPBBKDPCN
Date   Source Headline
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.